€187.10
1.93% today
Xetra, Aug 12, 02:13 pm CET
ISIN
DE0007165631
Symbol
SRT3
Index

Sartorius Vz Stock price

€183.55
-36.95 16.76% 1M
-65.55 26.31% 6M
-31.65 14.71% YTD
-57.55 23.87% 1Y
-259.45 58.57% 3Y
-148.45 44.71% 5Y
+134.10 271.18% 10Y
+178.08 3,252.51% 20Y
Xetra, Closing price Mon, Aug 11 2025
+2.55 1.41%
ISIN
DE0007165631
Symbol
SRT3
Index

Key metrics

Basic
Market capitalization
€11.4b
Enterprise Value
€15.2b
Net debt
€3.8b
Cash
€822.5m
Shares outstanding
69.0m
Valuation (TTM | estimate)
P/E
121.6 | 36.5
P/S
3.3 | 3.2
EV/Sales
4.4 | 4.2
EV/FCF
26.5
P/B
4.3
Dividends
DPS
€0.74
Yield 1Y | 5Y
0.4% | 0.3%
Growth 1Y | 5Y
0.0% | 15.5%
Payout 1Y | 3Y
60.7% | 20.7%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€3.5b | €3.6b
EBITDA
€859.3m | €1.1b
EBIT
€432.9m | €646.3m
Net Income
€104.1m | €347.7m
Free Cash Flow
€575.3m
Growth (TTM | estimate)
Revenue
3.8% | 6.4%
EBITDA
5.5% | 22.7%
EBIT
1.0% | 44.0%
Net Income
34.1% | 313.9%
Free Cash Flow
64.3%
Margin (TTM | estimate)
Gross
45.8%
EBITDA
24.8% | 29.5%
EBIT
12.5%
Net
3.0% | 9.7%
Free Cash Flow
16.6%
Financial Health
Equity Ratio
27.4%
Return on Equity
3.0%
ROCE
5.1%
ROIC
3.8%
Debt/Equity
1.8
More
EPS
€1.5
FCF per Share
€8.3
Short interest
-
Employees
14k
Rev per Employee
€250.0k
Show more

Create a Free Account to create an Sartorius Vz alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Sartorius Vz Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Sartorius Vz forecast:

5x Buy
71%
2x Hold
29%

Analyst Opinions

7 Analysts have issued a Sartorius Vz forecast:

Buy
71%
Hold
29%

Financial data from Sartorius Vz

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
3,468 3,468
4% 4%
100%
- Direct Costs 1,881 1,881
1% 1%
54%
1,587 1,587
8% 8%
46%
- Selling and Administrative Expenses 892 892
0% 0%
26%
- Research and Development Expense 198 198
11% 11%
6%
859 859
6% 6%
25%
- Depreciation and Amortization 426 426
11% 11%
12%
EBIT (Operating Income) EBIT 433 433
1% 1%
12%
Net Profit 104 104
34% 34%
3%

In millions EUR.

Don't miss a Thing! We will send you all news about Sartorius Vz directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sartorius Vz Stock News

AD HOC NEWS
about 15 hours ago
Aus Sicht des Analysehauses Jefferies lohnt sich wegen guter Aussichten derzeit ein Investment in den Sartorius DE0007165631-Konzern gleich auf mehrfache Weise.
AD HOC NEWS
about 15 hours ago
Bei den im Dax notierten Vorzugsaktien von Sartorius DE0007165631 nimmt die jüngste Erholung vom Tief seit April am Dienstag etwas Gestalt an.
AD HOC NEWS
about 15 hours ago
Das Analysehaus Jefferies hat Sartorius DE0007165631 von "Hold" auf "Buy" hochgestuft und das Kursziel von 217 auf 263 Euro angehoben.
More Sartorius Vz News

Company Profile

Sartorius AG is an international laboratory and process technology provider for the biotech, pharmaceutical, and food industries. It operates through the Bioprocess Solutions and Lab Products and Services divisions. The Bioprocess Solutions division focuses on the major areas of activity of filtration, fluid management, fermentation, and purification. The Lab Products and Services division focuses on lab balances, pipettes, and laboratory water purification systems. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.

Head office Germany
CEO Joachim Kreuzburg
Employees 13,573
Founded 1870
Website www.sartorius.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today